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ABSTRACT
BACKGROUND: This is an update of a Cochrane review that was first 
published in 2011 of the effects of reducing dietary salt intake, through 
advice to reduce salt intake or low-sodium salt substitution, on mortal-
ity and cardiovascular events.
OBJECTIVES: 1. To assess the long-term effects of advice and salt sub-
stitution, aimed at reducing dietary salt, on mortality and cardiovascular 
morbidity. 2. To investigate whether a reduction in blood pressure is an 
explanatory factor in the effect of such dietary interventions on mortal-
ity and cardiovascular outcomes.
METHODS:
Search methods: We updated the searches of CENTRAL (2013, Issue 4), 
MEDLINE (OVID, 1946 to April week 3 2013), EMBASE (OVID, 1947 to 30 
April 2013) and CINAHL (EBSCO, inception to 1 April 2013) and last ran 
these on 1 May 2013. We also checked the references of included stud-
ies and reviews. We applied no language restrictions.
Selection criteria: Trials fulfilled the following criteria: (1) randomised, 
with follow-up of at least six months, (2) the intervention was reduced 
dietary salt (through advice to reduce salt intake or low-sodium salt 
substitution), (3) participants were adults and (4) mortality or cardiovas-
cular morbidity data were available. Two review authors independently 
assessed whether studies met these criteria.
Data collection and analysis: A single author extracted data and assessed 
study validity, and a second author checked this. We contacted trial au-
thors where possible to obtain missing information. We extracted events 
and calculated risk ratios (RRs) and 95% confidence intervals (CIs).
MAIN RESULTS: Eight studies met the inclusion criteria: three in nor-
motensives (n = 3518) and five in hypertensives or mixed populations 
of normo- and hypertensives (n = 3766). End of trial follow-up ranged 
from six to 36 months and the longest observational follow-up (after 
trial end) was 12.7 years.
The risk ratios (RR) for all-cause mortality in normotensives were im-
precise and showed no evidence of reduction (end of trial RR 0.67, 
95% confidence interval (CI) 0.40 to 1.12, 60 deaths; longest follow-up 
RR 0.90, 95% CI 0.58 to 1.40, 79 deaths n = 3518) or in hypertensives 
(end of trial RR 1.00, 95% CI 0.86 to 1.15, 565 deaths; longest follow-up 
RR 0.99, 95% CI 0.87 to 1.14, 674 deaths n = 3085). 
There was weak evidence of benefit for cardiovascular mortality (hyper-
tensives: end of trial RR 0.67, 95% CI 0.45 to 1.01, 106 events n = 2656) 
and for cardiovascular events (hypertensives: end of trial RR 0.76, 95% CI 
0.57 to 1.01, 194 events, four studies, n = 3397; normotensives: at longest 
follow-up RR 0.71, 95% CI 0.42 to 1.20, 200 events; hypertensives: RR 0.77, 
95% CI 0.57 to 1.02, 192 events; pooled analysis of six trials RR 0.77, 95% 
CI 0.63 to 0.95, n = 5912). These findings were driven by one trial among 
retirement home residents that reduced salt intake in the kitchens of the 
homes, thereby not requiring individual behaviour change.
Advice to reduce salt showed small reductions in systolic blood pressure 
(mean difference (MD) -1.15 mmHg, 95% CI -2.32 to 0.02 n = 2079) and 
diastolic blood pressure (MD -0.80 mmHg, 95% CI -1.37 to -0.23 n = 2079) 
in normotensives and greater reductions in systolic blood pressure in 
hypertensives (MD -4.14 mmHg, 95% CI -5.84 to -2.43 n = 675), but no 
difference in diastolic blood pressure (MD -3.74 mmHg, 95% CI -8.41 to 
0.93 n = 675).
Overall many of the trials failed to report sufficient detail to assess their 
potential risk of bias. Health-related quality of life was assessed in one 
trial in normotensives, which reported significant improvements in 
well-being but no data were presented.
AUTHORS’ CONCLUSIONS: Despite collating more event data than pre-
vious systematic reviews of randomised controlled trials, there is insuf-
ficient power to confirm clinically important effects of dietary advice and 
salt substitution on cardiovascular mortality in normotensive or hyper-
tensive populations. Our estimates of the clinical benefits from advice to 
reduce dietary salt are imprecise, but are larger than would be predicted 
from the small blood pressure reductions achieved. Further well-powered 
studies would be needed to obtain more precise estimates. Our findings 
do not support individual dietary advice as a means of restricting salt in-
take. It is possible that alternative strategies that do not require individual 
behaviour change may be effective and merit further trials.
The abstract of this review is available from: http://onlinelibrary.wiley.
com/doi/10.1002/14651858.CD009217.pub3/abstract
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COMMENTS 
Dietary sodium restriction and cardiovascular disease prevention: 
should we quit?
High salt consumption (> 2.0 g/day) is possibly responsible for one 
in every ten deaths attributed to cardiovascular disease worldwide.1 
There  is a log-linear association between sodium intake and blood 
pressure values, and hypertension is the most important risk factor 
for cardiovascular diseases (CVDs), because of its elevated prevalence, 
underdiagnosis and undertreatment.2 The question that ensues is how 
efficacious dietary sodium restriction is in relation to blood pressure 
control and consequent prevention of cardiovascular events. Sodium 
restriction is a lifestyle change that is universally proposed for hyper-
tensive individuals, in addition to weight loss, physical exercise and 
cessation of smoking, with the ultimate goal of preventing CVDs and 
prolonging life. 
However, recent evidence from a Cochrane systematic review has cast 
doubts on the efficacy of dietary sodium restriction.3 The authors evaluat-
ed eight studies: three on normotensive populations (n = 3,518) and five 
on hypertensive or mixed populations of normotensive and hypertensive 
individuals (n = 3,766). The patients were followed up for periods rang-
ing from six months to 12.7 years. There were modest changes in systolic 
blood pressure: mean differences of -1.15 mmHg and -4.14 mmHg, re-
spectively among normotensive and hypertensive individuals. However, 
although there was a change in diastolic blood pressure of -0.8 mmHg 
among normotensive individuals, there were non-significant reductions 
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among hypertensive individuals. There were non-significant reductions 
in cardiovascular mortality among both normotensive and hypertensive 
individuals, and CVD events were found to be reduced only when the 
studies were pooled together (-23%). 
This review is limited by the lack of an objective measurement for sodium 
intake, such as urinary sodium excretion, for testing treatment compli-
ance. However, it suggests that behavioral changes are hard to attain and 
that their effects may be limited. The results shown here can be compared 
with those from the randomized Look AHEAD study, which failed to show 
any benefits from lifestyle changes among diabetic patients, simply be-
cause they did not follow the recommendations over the long term.4 It 
can be concluded that better ways of implementing lifestyle changes 
need to be developed, including in relation to dietary sodium restriction.
The results from this review do not mean that dietary sodium restric-
tion should simply no longer be recommended and that reliance should 
be placed only on medications for attaining CVD reduction.  
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